The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama

The University of South Alabama, Mitchell Cancer Institute is a clinical research site located in Mobile, Alabama, United States 36604.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

The University of South Alabama, Mitchell Cancer Institute has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer.

Sponsors: Genelux Corporation.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of South Alabama, Mitchell Cancer Institute?

The University of South Alabama, Mitchell Cancer Institute has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of South Alabama, Mitchell Cancer Institute conducted?

The University of South Alabama, Mitchell Cancer Institute has 1 clinical trials on record, with 1 currently active. Their work covers Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer, Fallopian Tube Cancer.

Is The University of South Alabama, Mitchell Cancer Institute accredited by Crixeo Health?

The University of South Alabama, Mitchell Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The University of South Alabama, Mitchell Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.